Focusing on development and production of low volume, high value specialty Active Pharmaceutical Ingredients.
Established in 1990 by Dr. Arie Gutman, FineTech has a proven track record of successfully developing and manufacturing low volume, high value complex APIs. Our International team of highly qualified scientists and engineers work in our state-of-the-art FDA approved facility to meet our customers’ needs.
All pilot and commercial API manufacturing is carried out in GMP-compliant and FDA-approved multipurpose reactors.
Spaning from paper chemistry and literature searches through pilot scale-up and commercialization.